YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers. Katayama Y, Yamada T, Tanimura K, Kawachi H, et al. Clin Cancer Res 2025;31:1127-1141.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Katayama Y, Yamada T, Tanimura K, Kawachi H, et al. YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers. Clin Cancer Res 2025;31:1127-1141.
PMID: 39495173